Stock Screener App

Frei -

Installieren

6.78

2.45% -0.17

Entrada Therapeutics Inc (TRDA)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Entrada Therapeutics Inc-Aktie (TRDA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	90.51% 1.95	20.56	19.57	94.69	59.12
Operating Expenses	15.23% 48.80	42.35	41.23	41.27	38.01
Benefits Costs and Expenses	100.00% -	37.91	-	-	-
Costs And Expenses	28.73% 48.80	37.91	41.23	41.27	38.01
Operating Income/Loss	115.00% -46.85	-21.79	-21.66	53.42	21.11
Income/Loss From Continuing Operations Before Tax	111.24% 1.95	-17.35	19.57	55.03	23.50
Income Tax Expense/Benefit	0.178	-	-1.86	2.758	1.831
Income/Loss From Continuing Operations After Tax	148.45% -43.10	-17.35	-14.03	55.03	23.50
Net Income/Loss	148.45% -43.10	-17.35	-14.03	55.03	23.50
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.65% 41.34	41.07	40.63	34.18	33.50
Diluted Average Shares	0.65% 41.34	41.07	40.63	35.51	34.79
Basic Earnings Per Share	147.62% -1.04	-0.42	-0.35	1.61	0.70
Diluted Earnings Per Share	147.62% -1.04	-0.42	-0.35	1.55	0.68
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.30

0.64%

GMAB

$28.71

0.35%

INCY

$101.57

8.65%

BNTX

$103.95

0.04%

ONC

$311.86

0.44%

INSM

$186.23

1.78%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters